CRU is designed with a flexible layout that can be adapted to the needs of research procedures.

Facilities include:

• Informed consent room
• Changing room and lockers
• Meeting room
• Examination room
• Pharmacy room
• Staff and document room
• Biobank and sample processing facilities

• Drug Research and Clinical Trials
• Medical Device Research
• Bioequivalence Studies
• Vaccine Research
• Digital Health Studies (Applications and Software)
• Molecular Laboratory Services (Pathogen Detection, Antibiotic Resistance, and Genetic Analysis)

CRU RSA UGM has extensive experience in various types of clinical research, both nationally and internationally, including early- and late-phase clinical trials, bioequivalence studies, and collaborations with pharmaceutical companies, medical device companies, academic institutions, and global organizations.

CRU actively collaborates with various national and international partners and participates in scientific conferences, academic visits, and global research networks to promote innovation and improve the quality of clinical research.

CRU RSA UGM continues to develop its research facilities and capabilities, including strengthening its biobank and genomic and genetic laboratories, as well as planning a CRU building that meets biosafety principles to support infectious and non-infectious research.